Target type: biologicalprocess
Any process that increases the rate, frequency or extent of pancreatic juice secretion, the regulated release of pancreatic juice by the exocrine pancreas into the upper part of the intestine. [GOC:BHF, GOC:dph, GOC:tb]
Positive regulation of pancreatic juice secretion is a complex process that involves a cascade of signaling events, initiated by the arrival of food in the duodenum. This intricate interplay of hormones, neurotransmitters, and intracellular signaling pathways culminates in the release of digestive enzymes and bicarbonate ions from the pancreas, essential for efficient digestion.
The process begins with the detection of food entering the duodenum. This triggers the release of various stimuli, including:
* **Cholecystokinin (CCK):** A hormone released from the duodenum in response to the presence of fats and amino acids. CCK acts on the pancreas, stimulating the release of digestive enzymes like lipase, amylase, and protease.
* **Secretin:** Another hormone released from the duodenum, primarily in response to acidic chyme. Secretin acts on the pancreas, inducing the secretion of bicarbonate ions, which neutralize the acidic chyme, creating an optimal pH for digestive enzyme activity.
* **Acetylcholine (ACh):** A neurotransmitter released by the vagus nerve, which stimulates the release of both digestive enzymes and bicarbonate ions from the pancreas.
These stimuli activate specific receptors on pancreatic acinar cells and duct cells, leading to a series of intracellular signaling events:
* **CCK receptor (CCK-R) activation:** Binding of CCK to its receptor on acinar cells initiates a G protein-coupled signaling pathway. This pathway activates phospholipase C (PLC), leading to the production of inositol triphosphate (IP3) and diacylglycerol (DAG). IP3 promotes the release of calcium ions (Ca2+) from intracellular stores, while DAG activates protein kinase C (PKC). Both Ca2+ and PKC play crucial roles in the exocytosis of digestive enzymes from acinar cells.
* **Secretin receptor (SCTR) activation:** Secretin binds to its receptor on duct cells, triggering a signaling pathway that activates adenylyl cyclase, leading to the production of cyclic adenosine monophosphate (cAMP). cAMP activates protein kinase A (PKA), which in turn promotes the secretion of bicarbonate ions from duct cells.
* **Muscarinic acetylcholine receptor (mAChR) activation:** Acetylcholine binds to mAChRs on both acinar and duct cells, initiating signaling pathways similar to those activated by CCK and secretin, respectively.
The combined effect of these signaling pathways results in the release of pancreatic juice, containing a cocktail of digestive enzymes and bicarbonate ions. The precise composition of the juice varies depending on the type and amount of food ingested, ensuring optimal digestion of various dietary components.'
"
Protein | Definition | Taxonomy |
---|---|---|
Oxysterols receptor LXR-beta | An oxysterols receptor LXR-beta that is encoded in the genome of human. [PRO:DNx, UniProtKB:P55055] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
4-chlorophenol | 4-chlorophenol : A monochlorophenol substituted at the pare position by a chlorine atom. 4-chlorophenol: used as a root canal irrigant | monochlorophenol | |
butylparaben | organic molecular entity | ||
3-chlorophenol | 3-chlorophenol : A monochlorophenol carrying the chloro substituent at position 3. | monochlorophenol | |
4-phenoxyphenol | phenoxyphenol | ||
bis(4-oxyphenyl)sulfide | 4,4'-thiodiphenol: structure in first source | phenols | |
1-deoxynojirimycin | 1-deoxy-nojirimycin: structure in first source duvoglustat : An optically active form of 2-(hydroxymethyl)piperidine-3,4,5-triol having 2R,3R,4R,5S-configuration. | 2-(hydroxymethyl)piperidine-3,4,5-triol; piperidine alkaloid | anti-HIV agent; anti-obesity agent; bacterial metabolite; EC 3.2.1.20 (alpha-glucosidase) inhibitor; hepatoprotective agent; hypoglycemic agent; plant metabolite |
betulinic acid | hydroxy monocarboxylic acid; pentacyclic triterpenoid | anti-HIV agent; anti-inflammatory agent; antimalarial; antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; plant metabolite | |
bexarotene | benzoic acids; naphthalenes; retinoid | antineoplastic agent | |
podocarpic acid | podocarpic acid : An abietane diterpenoid lacking the isopropyl substituent with an aromatic C-ring and a hydroxy group at the 12-position. podocarpic acid: structure | abietane diterpenoid | |
cyanidin | cyanidin cation : An anthocyanidin cation that is flavylium substituted at positions 3, 3', 4', 5 and 7 by hydroxy groups. cyanidin: RN given refers to parent cpd; structure | 5-hydroxyanthocyanidin | antioxidant; metabolite; neuroprotective agent |
(22r)-22-hydroxycholesterol | (22R)-22-hydroxycholesterol : An oxysterol that is the 22R-hydroxy derivative of cholesterol. | 22-hydroxy steroid; 3beta-hydroxy-Delta(5)-steroid; oxysterol | |
2-chloro-1,4-dimethoxybenzene | dimethoxybenzene | ||
gw 3965 | GW 3965: a liver X receptor ligand | diarylmethane | |
t0901317 | T0901317: an LXRalpha and LXRbeta agonist | ||
alitretinoin | Alitretinoin: A retinoid that is used for the treatment of chronic hand ECZEMA unresponsive to topical CORTICOSTEROIDS. It is also used to treat cutaneous lesions associated with AIDS-related KAPOSI SARCOMA. | retinoic acid | antineoplastic agent; keratolytic drug; metabolite; retinoid X receptor agonist |
24,25-epoxycholesterol | 24,25-epoxycholesterol: Rn given refers to (3alpha,5beta)-isomer; structure given in first source 24(S),25-epoxycholesterol : A 3beta-hydroxy-Delta(5)-steroid that is desmosterol in which the double bond at position 24-25 has been oxidised to the corresponding epoxide (the 24S diastereoisomer). It is an oxysterol agonist of the liver X receptor. | 3beta-hydroxy-Delta(5)-steroid; cholestanoid; epoxy steroid | liver X receptor agonist |
genistein | 7-hydroxyisoflavones | antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; geroprotector; human urinary metabolite; phytoestrogen; plant metabolite; tyrosine kinase inhibitor | |
pregna-4,17-diene-3,16-dione | pregna-4,17-diene-3,16-dione: steroid from guggulu extract; RN & N1 from C1 Form index; RN given refers to cpd without isomeric designation; structure in first source; antagonist of farnesoid X receptor | 3-hydroxy steroid | androgen |
acanthoic acid | acanthoic acid: from root bark of Acanthopanax koreanum; structure given in first source | ||
3-chloro-4-(3-(7-propyl-3-trifluoromethyl-6-benzisoxazolyl)propylthio)phenylacetic acid | |||
riccardin c | riccardin C: isolated from liverworts; functions as a liver X receptor (LXR)alpha agonist and an LXRbeta antagonist; structure in first source | ||
bms 687453 | |||
way 252623 | 2-(2-chloro-4-fluorobenzyl)-3-(4-fluorophenyl)-7-(trifluoromethyl)-2H-indazole: a partial LXR agonist | ||
incb-018424 | nitrile; pyrazoles; pyrrolopyrimidine | antineoplastic agent; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor | |
sr9238 | SR9238: liver-selective LXR inverse agonist that suppresses hepatic steatosis; structure in first source |